Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining.
Rapid Discovery of Potential Drugs for Osteonecrosis of Femoral Head Based on Gene Expression Omnibus Database and Connectivity Map.
Comprehensive analysis of pivotal biomarkers, immune cell infiltration and therapeutic drugs for steroid-induced osteonecrosis of the femoral head.
Exogenous melatonin ameliorates steroid-induced osteonecrosis of the femoral head by modulating ferroptosis through GDF15-mediated signaling.
Li W, Li W, Zhang W, Wang H, Yu L, Yang P, Qin Y, Gan M, Yang X, Huang L, Hao Y, Geng D.
Stem Cell Res Ther. 2023 Jul 3;14(1):171. doi: 10.1186/s13287-023-03371-y.
Advances in experimental models of osteonecrosis of the femoral head.
Li Z, Shao W, Lv X, Wang B, Han L, Gong S, Wang P, Feng Y.
J Orthop Translat. 2023 Feb 3;39:88-99. doi: 10.1016/j.jot.2023.01.003. eCollection 2023 Mar.
Research Progress on Exosomes in Osteonecrosis of the Femoral Head.
Liu X, Wang C, Meng H, Liao S, Zhang J, Guan Y, Tian H, Peng J.
Orthop Surg. 2022 Sep;14(9):1951-1957. doi: 10.1111/os.13393. Epub 2022 Aug 4.
Engineered Exosome-Functionalized Extracellular Matrix-Mimicking Hydrogel for Promoting Bone Repair in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.
Chen C, Fu L, Luo Y, Zeng W, Qi X, Wei Y, Chen L, Zhao X, Li D, Tian M, Kang P.
ACS Appl Mater Interfaces. 2023 Jun 21;15(24):28891-28906. doi: 10.1021/acsami.3c01539. Epub 2023 Jun 12.
Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway.
Chen XJ, Shen YS, He MC, Yang F, Yang P, Pang FX, He W, Cao YM, Wei QS.
Biomed Pharmacother. 2019 Apr;112:108746. doi: 10.1016/j.biopha.2019.108746. Epub 2019 Mar 2.
Lycium barbarum polysaccharide protects against osteonecrosis of femoral head via regulating Runx2 expression.
Song Q, Yong HM, Yang LL, Liang YQ, Liu ZX, Niu DS, Bai ZG.
Injury. 2022 Apr;53(4):1361-1367. doi: 10.1016/j.injury.2021.12.056. Epub 2022 Jan 12.
Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining.
Tang L, Li B, Su Q, Chen X, He R.
Sci Rep. 2023 Jul 24;13(1):11972. doi: 10.1038/s41598-023-39258-4.
Screening and identification of potential key biomarkers for glucocorticoid-induced osteonecrosis of the femoral head.
Chen D, Zhong D, Mei R, Qian S, Wang P, Chen K, Yu X.
J Orthop Surg Res. 2023 Jan 11;18(1):28. doi: 10.1186/s13018-022-03465-y.
The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature.
Wang A, Ren M, Wang J.
Gene. 2018 Sep 10;671:103-109. doi: 10.1016/j.gene.2018.05.091. Epub 2018 May 30.
Early diagnosis and treatment of steroid-induced osteonecrosis of the femoral head.
Fu W, Liu B, Wang B, Zhao D.
Int Orthop. 2019 May;43(5):1083-1087. doi: 10.1007/s00264-018-4011-y. Epub 2018 Jun 6.
